A more intensive postoperative chemotherapy regimen for high-risk gastric cancer patients did not improve their survival, according to a randomized controlled trial in the April 18 Journal of the National Cancer Institute.
Most attempts to create therapeutic cancer vaccines are based on custom-made approaches that use a patient’s own tumor cells to generate a strong immune response against cancer.
A new study from the University of Pittsburgh Cancer Institute suggests that a commonly used herbal supplement, triphala, has cancer-fighting properties that prevent or slow the growth of pancreatic cancer tumors implanted in mice.
Chemicals in cruciferous vegetables, such as broccoli, watercress, cabbage and cauliflower, appear to not only stop human prostate cancer cells from growing in mice but also may cut off the formation of blood vessels that “feed” tumors, says a University of Pittsburgh Cancer Institute study.
Despite the high profile given to hand washing in hospitals, there is still little robust evidence to show which are the best ways to improve hand hygiene.
Johns Hopkins University researchers have cured malaria-infected mice with single shots of a new series of potent, long lasting synthetic drugs modeled on an ancient Chinese herbal folk remedy.
Legislation that requires people to wear bicycle helmets appears to increase use and decreases injury rates, according to the results of a Cochrane Review. Cycling is a popular pastime and a mode of transport for children, but it also leads to many injuries that are frequently sufficiently severe to require hospitalisation. This is a global problem, and particularly effects low-income countries where the proportion of cycle-users is high.
Women who have unprotected sexual intercourse or experience contraceptive failure can seek emergency contraception to reduce their chance of unintended pregnancy. Emergency contraception is a safe medication, and to be effective, must be taken within five days of unprotected intercourse.
According to a study that appears in the April 17 issue of Neurology, researchers at the University of Pennsylvania School of Medicine have found that natalizumab (TYSABRI?) ? a drug that slows disability and reduces relapse rates in patients with multiple sclerosis (MS) ? also reduces vision loss in patients with relapsing MS.
Research has shown there is a connection between reproductive factors?such as age at first birth, number of births, and breastfeeding?and a woman?s risk of breast cancer.